Press Releases Press Releases Year: - Any -20202019201820172016201520142013 August 09, 2019 Summary ToggleMelinta Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update August 06, 2019 Summary ToggleMelinta Therapeutics Announces Rescheduling of Second Quarter 2019 Financial Results Reporting July 16, 2019 Summary ToggleMelinta Therapeutics Announces Preliminary Second Quarter 2019 Financial Results and Provides Corporate Update June 19, 2019 Summary ToggleMelinta Therapeutics Announces U.S. FDA Acceptance of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia May 09, 2019 Summary ToggleMelinta Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update May 07, 2019 Summary ToggleMelinta Therapeutics to Present at Making a Difference in Infectious Diseases (MAD-ID) 2019 Annual Meeting May 02, 2019 Summary ToggleMelinta Therapeutics to Report First Quarter 2019 Financial Results on May 9, 2019 April 08, 2019 Summary ToggleMelinta Therapeutics Announces Multiple Presentations at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) March 13, 2019 Summary ToggleMelinta Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results March 05, 2019 Summary ToggleMelinta Therapeutics to Report Fourth Quarter and Year-End 2018 Financial Results on March 13, 2019 Pagination First page First Previous page Previous Page 1 Current page 2 Page 3 Page 4 … Next page Next Last page Last
Press Releases Year: - Any -20202019201820172016201520142013 August 09, 2019 Summary ToggleMelinta Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update August 06, 2019 Summary ToggleMelinta Therapeutics Announces Rescheduling of Second Quarter 2019 Financial Results Reporting July 16, 2019 Summary ToggleMelinta Therapeutics Announces Preliminary Second Quarter 2019 Financial Results and Provides Corporate Update June 19, 2019 Summary ToggleMelinta Therapeutics Announces U.S. FDA Acceptance of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia May 09, 2019 Summary ToggleMelinta Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update May 07, 2019 Summary ToggleMelinta Therapeutics to Present at Making a Difference in Infectious Diseases (MAD-ID) 2019 Annual Meeting May 02, 2019 Summary ToggleMelinta Therapeutics to Report First Quarter 2019 Financial Results on May 9, 2019 April 08, 2019 Summary ToggleMelinta Therapeutics Announces Multiple Presentations at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) March 13, 2019 Summary ToggleMelinta Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results March 05, 2019 Summary ToggleMelinta Therapeutics to Report Fourth Quarter and Year-End 2018 Financial Results on March 13, 2019 Pagination First page First Previous page Previous Page 1 Current page 2 Page 3 Page 4 … Next page Next Last page Last
